Myriad Genetics Inc (MYGN)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
| 06-2020 | 12-2019 | 06-2019 | 06-2018 | 06-2017 | |
| Sales | 638,600 | 0 | 851,100 | 743,700 | 728,700 |
| Cost of Goods | 186,100 | N/A | 201,000 | 177,200 | 171,200 |
| Gross Profit | 452,500 | N/A | 650,100 | 566,500 | 557,500 |
| Operating Expenses | 684,300 | 0 | 642,500 | 444,800 | 513,700 |
| Operating Income | -231,700 | N/A | 7,600 | 121,900 | 44,000 |
| Interest Expense | 10,800 | 0 | 12,000 | 3,200 | 6,000 |
| Other Income | 19,200 | 0 | 4,400 | 1,400 | -1,800 |
| Pre-tax Income | -223,300 | 0 | 0 | 120,100 | 36,200 |
| Income Tax | -23,700 | N/A | -4,400 | -13,000 | 19,000 |
| Net Income Continuous | -199,600 | N/A | 4,400 | 133,100 | 17,200 |
| Minority Interests | -100 | N/A | -200 | -200 | -200 |
| Net Income | $-199,500 | $N/A | $4,600 | $133,300 | $17,400 |
| EPS Basic Total Ops | -2.69 | N/A | 0.06 | 1.92 | 0.25 |
| EPS Basic Continuous Ops | -2.69 | N/A | 0.06 | 1.92 | 0.25 |
| EPS Diluted Total Ops | -2.69 | N/A | 0.06 | 1.85 | 0.25 |
| EPS Diluted Continuous Ops | -2.69 | N/A | 0.06 | 1.85 | 0.25 |
| EPS Diluted Before Non-Recurring Items | N/A | 1.29 | N/A | N/A | N/A |
| EBITDA(a) | $-60,000 | $N/A | $80,600 | $176,300 | $92,300 |